GO:0003333 amino acid transmembrane transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003333 (amino acid transmembrane transport) describes the biological process in which an amino acid is transported across a membrane.
• Mammalian amino acid transport is mediated by multiple transporter families, including the glycoprotein-associated amino acid exchangers (LAT1/LAT2) that broaden transport specificity.
• Secondary transporters use ion gradients to drive amino acid translocation via an alternating-access mechanism.
• LAT1 (SLC7A5) is a major transporter for large neutral amino acids and is recognized as a target for anticancer drug recognition.
• Kidney amino acid transport is essential for reabsorption and metabolic homeostasis, and its dysfunction is linked to disease.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of amino acid transporter genes in health and disease.
Description
Amino acid transmembrane transport (GO:0003333) is the process in which an amino acid is transported across a membrane. This process is fundamental to cellular metabolism, protein synthesis, and signaling, and it is mediated by a diverse array of membrane-embedded transporter proteins. In mammals, amino acid transport systems are expressed in a tissue-specific manner, with the kidney playing a central role in amino acid reabsorption and homeostasis. The glycoprotein-associated amino acid exchangers, such as LAT1 and LAT2, are key examples of transporters that broaden the range of transport specificity and are implicated in both normal physiology and disease. Understanding the molecular mechanisms of amino acid transmembrane transport is therefore critical for researchers studying metabolism, cancer, and neurological disorders. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0003333, its genes, functions, and experimental approaches.
amino acid transmembrane transport At A Glance
| GO ID | GO:0003333 |
|---|---|
| GO term | amino acid transmembrane transport |
| Ontology | biological_process |
| Synonym | amino acid membrane transport |
| Major function | Translocation of amino acids across a membrane |
| Major transporter families | Glycoprotein-associated amino acid exchangers (LAT1/LAT2), secondary transporters |
| Tissue examples | Kidney, intestine, brain |
| Disease relevance | Cancer, metabolic disorders, neurological conditions |
What Is GO:0003333?
GO:0003333 (amino acid transmembrane transport) is defined as the process in which an amino acid is transported across a membrane. This biological process encompasses the movement of amino acids from one side of a lipid bilayer to the other, typically mediated by integral membrane transport proteins. The process is distinct from amino acid biosynthesis or catabolism and is instead focused on the translocation event itself.
Why Is amino acid transmembrane transport Important in Cell Biology?
Amino acid transmembrane transport is essential for nutrient uptake, metabolic regulation, and cell signaling, and its dysregulation is implicated in a wide range of human diseases. In the kidney, amino acid transporters are critical for reabsorption and maintaining systemic amino acid balance. In cancer, transporters such as LAT1 are upregulated to support the high metabolic demands of tumor cells and are being explored as drug targets. In the intestine, amino acid transport systems mediate dietary amino acid absorption. Thus, understanding GO:0003333 provides mechanistic insight into physiology and disease.
• Essential for amino acid uptake and cellular metabolism.
• Critical for kidney amino acid reabsorption and homeostasis.
• Mediates intestinal absorption of dietary amino acids.
• LAT1 is a target for anticancer drug recognition and transport.
• Glycoprotein-associated exchangers broaden transport specificity.
• Secondary transporters use ion gradients for amino acid translocation.
• Dysregulation linked to metabolic and neurological disorders.
• Provides targets for pharmacological intervention in cancer.
• Fundamental to protein synthesis and cell growth.
• Modeled using CRISPR knockout and knock-in approaches.
What Happens During amino acid transmembrane transport?
Substrate recognition and binding
In simple terms: The transporter first grabs the amino acid it needs to move.
Amino acid transporters recognize their substrates with varying degrees of specificity. The glycoprotein-associated amino acid exchangers, such as LAT1 and LAT2, form heterodimeric complexes with the 4F2 heavy chain (CD98) and mediate the exchange of large neutral amino acids. Structural studies of LAT1 have revealed the basis for anticancer drug recognition and amino acid transport, highlighting the importance of substrate binding pockets.
Conformational change and translocation
In simple terms: The transporter changes shape to carry the amino acid across the membrane.
Secondary transporters, including the glycoprotein-associated exchangers, operate via an alternating-access mechanism in which the transporter alternates between outward-facing and inward-facing conformations to move the substrate across the membrane. This process is driven by ion gradients, typically sodium or proton gradients, depending on the transporter family.
Substrate release and reset
In simple terms: The amino acid is released inside the cell, and the transporter resets for another round.
After translocation, the amino acid is released into the cytoplasm, and the transporter returns to its original conformation to complete the cycle. For exchangers, the process is coupled to the counter-transport of another amino acid, maintaining intracellular amino acid homeostasis.
Regulation by cellular signals
In simple terms: The cell can speed up or slow down transport based on its needs.
Amino acid transport activity is regulated by cellular signals, including nutrient availability and hormonal cues. In the kidney, amino acid transport systems are subject to regulation to maintain systemic amino acid balance. The expression and activity of transporters such as LAT1 can be modulated in response to metabolic demands.
Key Genes Involved in GO:0003333 amino acid transmembrane transport
The following genes encode transporters and associated proteins that mediate amino acid transmembrane transport (GO:0003333).
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC7A5 (LAT1) | Large neutral amino acid transporter | Anticancer drug target; structural studies |
| SLC3A2 (CD98hc) | Heavy chain partner for LAT1/LAT2 | Glycoprotein-associated exchanger function |
| SLC7A8 (LAT2) | Large neutral amino acid transporter | Broad transport specificity |
| SLC7A7 (y+LAT1) | Cationic and neutral amino acid transport | Kidney and intestinal transport |
| SLC7A6 (y+LAT2) | Cationic and neutral amino acid transport | Broad specificity exchanger |
| SLC7A9 (b0,+AT) | Cystine and dibasic amino acid transport | Kidney reabsorption |
| SLC7A11 (xCT) | Cystine/glutamate exchange | Redox homeostasis and cancer |
| SLC1A1 (EAAT3) | Glutamate/aspartate transport | Neuronal and epithelial transport |
| SLC1A2 (EAAT2) | Glutamate transport | Neurotransmitter clearance |
| SLC6A19 (B0AT1) | Neutral amino acid transport | Intestinal and kidney absorption |
| SLC36A1 (PAT1) | Proton-coupled amino acid transport | Intestinal absorption |
| SLC38A1 (SNAT1) | System A glutamine transport | Metabolic regulation |
| SLC38A2 (SNAT2) | System A amino acid transport | Nutrient sensing |
| SLC43A1 (LAT3) | Large neutral amino acid transport | System L-like transport |
| SLC43A2 (LAT4) | Large neutral amino acid transport | System L-like transport |
| SLC16A10 (TAT1) | Aromatic amino acid transport | Thyroid and kidney transport |
| SLC25A29 | Mitochondrial amino acid transport | Mitochondrial metabolism |
How Is amino acid transmembrane transport Regulated?
Amino acid transmembrane transport is regulated at multiple levels, including transcriptional control, post-translational modifications, and substrate availability. In the kidney, transport activity is adjusted to maintain amino acid homeostasis, and hormonal signals can influence transporter expression. The glycoprotein-associated amino acid exchangers are regulated by the availability of their heavy chain partner, CD98, and by cellular signals that control their surface expression. Additionally, LAT1 expression is responsive to metabolic demands and is a target of anticancer drug recognition.
amino acid transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC7A5 (LAT1) | Cancer metabolism and drug response | Knockout and overexpression in cancer cell lines |
| SLC3A2 (CD98hc) | Tumor growth and immune regulation | Knockout and knock-in models |
| SLC7A7 | Lysinuric protein intolerance | Patient-derived cells and knockout models |
| SLC6A19 | Hartnup disorder | Knockout and point mutation models |
| SLC7A9 | Cystinuria | Knockout and knock-in models |
Cancer metabolism and drug targeting
Amino acid transporters, particularly LAT1 (SLC7A5), are upregulated in many cancers to support the increased demand for amino acids required for proliferation. Structural studies have revealed how LAT1 recognizes both amino acids and anticancer drugs, providing a basis for therapeutic targeting. The glycoprotein-associated exchangers also contribute to tumor metabolism by broadening transport specificity.
Kidney disorders and aminoacidurias
Kidney amino acid transport is essential for reabsorption, and defects in specific transporters can lead to aminoacidurias and related metabolic disorders. The coordinated action of multiple transporters in the proximal tubule maintains systemic amino acid balance.
Intestinal absorption and metabolic disease
Intestinal amino acid transport systems mediate the absorption of dietary amino acids, and their dysfunction can contribute to metabolic imbalances. Studies in lepidopteran larvae have characterized brush-border membrane transport systems, providing comparative insights.
From amino acid transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of LAT1 affect cancer cell proliferation? | CRISPR knockout in cancer cell lines |
| How does a point mutation alter substrate specificity? | CRISPR point mutation knock-in |
| Can a tagged transporter be used for localization studies? | Tagged knock-in |
| Does overexpression of SLC7A5 increase amino acid uptake? | Overexpression cell model |
| What is the role of CD98hc in transporter stability? | Knockout and rescue models |
| How do intestinal transporters mediate dietary absorption? | Knockout and overexpression in intestinal cells |
How to Study the amino acid transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled uptake assay | Transport activity | Functional characterization of transporters |
| Cryo-EM | Protein structure | Mechanistic studies of transport |
| RNA-seq | Gene expression | Profiling transporter expression |
| Proteomics | Protein abundance | Quantifying transporter levels |
| CRISPR knockout | Gene function | Loss-of-function studies |
| CRISPR knock-in | Mutant protein function | Point mutation analysis |
| Overexpression | Gain-of-function | Testing sufficiency |
| Library screening | Gene essentiality | Identifying novel transport regulators |
Transport assays
Radiolabeled or fluorescent amino acid uptake assays are used to measure transport activity in cells and membrane vesicles. These assays can be performed in knockout or overexpression models to determine the contribution of specific transporters.
Structural biology
Cryo-EM and X-ray crystallography have provided structural insights into amino acid transporters, including LAT1, revealing substrate binding and translocation mechanisms.
Transcriptomics and proteomics
RNA-seq and proteomics can profile the expression of amino acid transporters across tissues and conditions, identifying candidates for functional studies.
Genetic screens
CRISPR library screening can identify genes required for amino acid transport and metabolism, linking transporters to cellular fitness.
How CRISPR Can Be Used to Study GO:0003333 amino acid transmembrane transport
Knockout
CRISPR knockout of amino acid transporter genes, such as SLC7A5, enables researchers to assess loss-of-function phenotypes, including changes in amino acid uptake, cell growth, and drug sensitivity. Knockout models are also used to study kidney and intestinal transport.
Point Mutation
CRISPR point mutation knock-in can introduce specific amino acid substitutions to dissect substrate binding and transport mechanisms, as demonstrated for LAT1. This approach is valuable for studying disease-associated variants.
Knock-in
Knock-in of tagged transporters (e.g., GFP or HA) allows visualization and biochemical isolation of transporter complexes, facilitating studies of localization and interaction partners such as CD98hc.
Overexpression
Overexpression of amino acid transporters in cell lines can test sufficiency for transport activity and downstream metabolic effects, and is used to model transporter upregulation in cancer.
How EDITGENE Supports amino acid transmembrane transport Research
Researchers studying amino acid transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in transport, metabolism, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for amino acid transmembrane transport research.
Frequently Asked Questions About amino acid transmembrane transport
What is amino acid transmembrane transport?
Amino acid transmembrane transport (GO:0003333) is the process in which an amino acid is transported across a membrane.
What genes are involved in amino acid transmembrane transport?
Genes include SLC7A5 (LAT1), SLC3A2 (CD98hc), SLC7A8 (LAT2), and many other solute carrier family members.
What is the function of LAT1 in amino acid transport?
LAT1 (SLC7A5) mediates the transport of large neutral amino acids and is a target for anticancer drug recognition.
How is amino acid transport regulated?
It is regulated by transcriptional, post-translational, and signaling mechanisms, including nutrient availability.
What diseases are linked to amino acid transport defects?
Diseases include cancer, kidney aminoacidurias, and metabolic disorders.
What methods are used to study amino acid transmembrane transport?
Methods include radiolabeled uptake assays, cryo-EM, RNA-seq, proteomics, and CRISPR screens.
What is the role of CD98hc in amino acid transport?
CD98hc (SLC3A2) is the heavy chain partner for glycoprotein-associated amino acid exchangers such as LAT1 and LAT2.
How do secondary transporters move amino acids?
They use ion gradients and an alternating-access mechanism to translocate amino acids across the membrane.
Can CRISPR be used to study amino acid transporters?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used.
What is the clinical relevance of amino acid transporters?
They are implicated in cancer metabolism, drug response, and metabolic disorders, making them potential therapeutic targets.
Conclusion
Amino acid transmembrane transport (GO:0003333) is a fundamental biological process mediated by diverse transporter families, with critical roles in metabolism, kidney function, intestinal absorption, and cancer. Understanding its molecular mechanisms and regulation provides opportunities for therapeutic intervention. CRISPR-based models and advanced screening methods continue to accelerate research in this field.
References
- 1. Verrey F et al.. 2009. Kidney amino acid transport.. Pflugers Arch 458(1):53-60 PMID: 19184091
- 3. Lee Y et al.. 2025. Structural basis of anticancer drug recognition and amino acid transport by LAT1.. Nat Commun 16(1):1635 PMID: 39952931
- 4. Schweikhard ES et al.. 2012. Amino acid secondary transporters: toward a common transport mechanism.. Curr Top Membr 70:1-28 PMID: 23177982
- 5. Kilberg MS et al.. 1993. Recent advances in mammalian amino acid transport.. Annu Rev Nutr 13:137-65 PMID: 8369142
- 6. Verrey F et al.. 2000. Glycoprotein-associated amino acid exchangers: broadening the range of transport specificity.. Pflugers Arch 440(4):503-12 PMID: 10958334
- 7. Verrey F et al.. 1999. New glycoprotein-associated amino acid transporters.. J Membr Biol 172(3):181-92 PMID: 10568788
- 8. Giordana B et al.. 1989. Amino acid transport systems in intestinal brush-border membranes from lepidopteran larvae.. Am J Physiol 257(3 Pt 2):R494-500 PMID: 2675638
